• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NAD 依赖的 SIR2 家族去乙酰化酶十年研究进展:与代谢性疾病的关系。

Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases.

机构信息

Department of Developmental Biology, Washington University School of Medicine, Saint Louis, MO 63110, USA.

出版信息

Trends Pharmacol Sci. 2010 May;31(5):212-20. doi: 10.1016/j.tips.2010.02.003. Epub 2010 Mar 11.

DOI:10.1016/j.tips.2010.02.003
PMID:20226541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3526941/
Abstract

Since the discovery of NAD-dependent deacetylase activity of the silent information regulator-2 (SIR2) family ('sirtuins'), many exciting connections between protein deacetylation and energy metabolism have been revealed. The importance of sirtuins in the regulation of many fundamental biological responses to various nutritional and environmental stimuli has been firmly established. Sirtuins have also emerged as critical regulators for aging and longevity in model organisms. Their absolute requirement of NAD has revived an enthusiasm in the study of mammalian biosynthesis of NAD. Sirtuin-targeted pharmaceutical and nutriceutical interventions against age-associated diseases are also on the horizon. This review summarizes the recent progress in sirtuin research (particularly in mammalian sirtuin biology) and re-evaluates the connection between sirtuins, metabolism, and age-associated diseases (e.g., type-2 diabetes) to set a basis for the next ten years of sirtuin research.

摘要

自从发现沉默信息调节因子-2(SIR2)家族的 NAD 依赖性去乙酰化酶活性(“sirtuins”)以来,已经揭示了蛋白质去乙酰化作用与能量代谢之间的许多令人兴奋的联系。Sirtuins 在调节各种营养和环境刺激的许多基本生物学反应中的重要性已得到牢固确立。Sirtuins 也是模型生物中衰老和长寿的关键调节剂。它们对 NAD 的绝对需求重新激发了人们对哺乳动物 NAD 生物合成的研究热情。针对与年龄相关疾病的靶向 Sirtuin 药物和营养干预措施也即将出现。本文综述了最近 Sirtuin 研究的进展(特别是在哺乳动物 Sirtuin 生物学方面),并重新评估了 Sirtuins、代谢与与年龄相关疾病(如 2 型糖尿病)之间的联系,为未来十年的 Sirtuin 研究奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2007/3526941/729ba5d31355/nihms182151f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2007/3526941/e866eeae1c24/nihms182151f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2007/3526941/444e0453b09e/nihms182151f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2007/3526941/729ba5d31355/nihms182151f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2007/3526941/e866eeae1c24/nihms182151f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2007/3526941/444e0453b09e/nihms182151f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2007/3526941/729ba5d31355/nihms182151f3.jpg

相似文献

1
Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases.NAD 依赖的 SIR2 家族去乙酰化酶十年研究进展:与代谢性疾病的关系。
Trends Pharmacol Sci. 2010 May;31(5):212-20. doi: 10.1016/j.tips.2010.02.003. Epub 2010 Mar 11.
2
Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications.靶向沉默调节蛋白的药物:作用机制及潜在治疗应用
Curr Opin Investig Drugs. 2010 Oct;11(10):1158-68.
3
A possibility of nutriceuticals as an anti-aging intervention: activation of sirtuins by promoting mammalian NAD biosynthesis.营养保健品作为抗衰老干预手段的可能性:通过促进哺乳动物 NAD 生物合成来激活沉默调节蛋白。
Pharmacol Res. 2010 Jul;62(1):42-7. doi: 10.1016/j.phrs.2010.01.006. Epub 2010 Jan 18.
4
Biology, Chemistry, and Pharmacology of Sirtuins.沉默调节蛋白的生物学、化学及药理学
Methods Enzymol. 2016;574:183-211. doi: 10.1016/bs.mie.2016.03.011. Epub 2016 Mar 28.
5
Inhibitors to understand molecular mechanisms of NAD(+)-dependent deacetylases (sirtuins).用于理解NAD⁺依赖性脱乙酰酶(沉默调节蛋白)分子机制的抑制剂。
Biochim Biophys Acta. 2010 Oct-Dec;1799(10-12):726-39. doi: 10.1016/j.bbagrm.2010.06.003. Epub 2010 Jun 23.
6
Sirtuin modulators: mechanisms and potential clinical implications.Sirtuin 调节剂:作用机制与潜在临床意义。
Curr Med Chem. 2012;19(15):2414-41. doi: 10.2174/092986712800269272.
7
"Clocks" in the NAD World: NAD as a metabolic oscillator for the regulation of metabolism and aging.NAD世界中的“时钟”:NAD作为调节新陈代谢和衰老的代谢振荡器。
Biochim Biophys Acta. 2010 Aug;1804(8):1584-90. doi: 10.1016/j.bbapap.2009.10.024. Epub 2009 Nov 6.
8
Yeast sirtuins and the regulation of aging.酵母沉默信息调节蛋白与衰老调控
FEMS Yeast Res. 2014 Feb;14(1):73-88. doi: 10.1111/1567-1364.12115. Epub 2013 Nov 14.
9
The role of mammalian sirtuins in the regulation of metabolism, aging, and longevity.哺乳动物沉默调节蛋白在代谢、衰老和寿命调节中的作用。
Handb Exp Pharmacol. 2011;206:125-62. doi: 10.1007/978-3-642-21631-2_7.
10
NAD⁺ metabolism: a therapeutic target for age-related metabolic disease.NAD⁺ 代谢:与年龄相关的代谢性疾病的治疗靶点。
Crit Rev Biochem Mol Biol. 2013 Jul-Aug;48(4):397-408. doi: 10.3109/10409238.2013.789479. Epub 2013 Jun 6.

引用本文的文献

1
TaHSP18.6 and TaSRT1 interact to confer resistance to crown rot by regulating the auxin content in common wheat.TaHSP18.6和TaSRT1相互作用,通过调节普通小麦中的生长素含量来赋予对冠腐病的抗性。
Proc Natl Acad Sci U S A. 2025 Jul 15;122(28):e2500029122. doi: 10.1073/pnas.2500029122. Epub 2025 Jul 9.
2
Unveiling the dynamics of acetylation and phosphorylation in SGBS and 3T3-L1 adipogenesis.揭示SGBS和3T3-L1脂肪生成过程中乙酰化和磷酸化的动态变化。
iScience. 2024 Apr 10;27(6):109711. doi: 10.1016/j.isci.2024.109711. eCollection 2024 Jun 21.
3
The global regulation of c-di-GMP and cAMP in bacteria.

本文引用的文献

1
A possibility of nutriceuticals as an anti-aging intervention: activation of sirtuins by promoting mammalian NAD biosynthesis.营养保健品作为抗衰老干预手段的可能性:通过促进哺乳动物 NAD 生物合成来激活沉默调节蛋白。
Pharmacol Res. 2010 Jul;62(1):42-7. doi: 10.1016/j.phrs.2010.01.006. Epub 2010 Jan 18.
2
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1.SRT1720、SRT2183、SRT1460 和白藜芦醇不是 SIRT1 的直接激活剂。
J Biol Chem. 2010 Mar 12;285(11):8340-51. doi: 10.1074/jbc.M109.088682. Epub 2010 Jan 8.
3
AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol.
细菌中c-di-GMP和cAMP的全局调控
mLife. 2024 Mar 11;3(1):42-56. doi: 10.1002/mlf2.12104. eCollection 2024 Mar.
4
Therapeutic Effects of Hinokitiol through Regulating the SIRT1/NOX4 against Ligature-Induced Experimental Periodontitis.扁柏酚通过调控SIRT1/NOX4对结扎诱导的实验性牙周炎的治疗作用
Antioxidants (Basel). 2024 Apr 30;13(5):550. doi: 10.3390/antiox13050550.
5
The Key Role of Mitochondria in Somatic Stem Cell Differentiation: From Mitochondrial Asymmetric Apportioning to Cell Fate.线粒体在体干细胞分化中的关键作用:从线粒体不对称分配到细胞命运。
Int J Mol Sci. 2023 Jul 29;24(15):12181. doi: 10.3390/ijms241512181.
6
Alterations of SIRT1/SIRT3 subcellular distribution in aging undermine cardiometabolic homeostasis during ischemia and reperfusion.SIRT1/SIRT3 亚细胞分布在衰老过程中的改变破坏了缺血再灌注期间的心脏代谢稳态。
Aging Cell. 2023 Sep;22(9):e13930. doi: 10.1111/acel.13930. Epub 2023 Aug 3.
7
CD38 Inhibition Protects Fructose-Induced Toxicity in Primary Hepatocytes.CD38 抑制物可保护原代肝细胞果糖诱导的毒性。
Mol Cells. 2023 Aug 31;46(8):496-512. doi: 10.14348/molcells.2023.0045. Epub 2023 Jul 27.
8
Comparative Lysine Acetylome Analysis of Y. pestis YfiQ/CobB Mutants Reveals that Acetylation of SlyA Lys73 Significantly Promotes Biofilm Formation of Y. pestis.比较 Y. pestis YfiQ/CobB 突变体的赖氨酸乙酰化组分析揭示,SlyA Lys73 的乙酰化显著促进 Y. pestis 生物膜的形成。
Microbiol Spectr. 2023 Aug 17;11(4):e0046023. doi: 10.1128/spectrum.00460-23. Epub 2023 Jul 17.
9
Virtual Screening Combined with Enzymatic Assays to Guide the Discovery of Novel SIRT2 Inhibitors.虚拟筛选结合酶活性测定指导新型 SIRT2 抑制剂的发现。
Int J Mol Sci. 2023 May 27;24(11):9363. doi: 10.3390/ijms24119363.
10
SIRT6-PAI-1 axis is a promising therapeutic target in aging-related bone metabolic disruption.SIRT6-PAI-1 轴是与衰老相关的骨骼代谢紊乱的有前途的治疗靶点。
Sci Rep. 2023 May 17;13(1):7991. doi: 10.1038/s41598-023-33297-7.
AMP 激活的蛋白激酶缺陷型小鼠对白藜芦醇的代谢作用具有抗性。
Diabetes. 2010 Mar;59(3):554-63. doi: 10.2337/db09-0482. Epub 2009 Nov 23.
4
"Clocks" in the NAD World: NAD as a metabolic oscillator for the regulation of metabolism and aging.NAD世界中的“时钟”:NAD作为调节新陈代谢和衰老的代谢振荡器。
Biochim Biophys Acta. 2010 Aug;1804(8):1584-90. doi: 10.1016/j.bbapap.2009.10.024. Epub 2009 Nov 6.
5
Resveratrol is not a direct activator of SIRT1 enzyme activity.白藜芦醇不是 SIRT1 酶活性的直接激活剂。
Chem Biol Drug Des. 2009 Dec;74(6):619-24. doi: 10.1111/j.1747-0285.2009.00901.x. Epub 2009 Oct 20.
6
SIRT1 genetic variation is related to BMI and risk of obesity.沉默调节蛋白1基因变异与体重指数及肥胖风险相关。
Diabetes. 2009 Dec;58(12):2828-34. doi: 10.2337/db09-0536. Epub 2009 Sep 9.
7
Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice.用 SIRT1 激活剂 SRT1720 治疗可改善 MSG 小鼠的脂肪肝,降低脂肪生成酶的表达。
Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E1179-86. doi: 10.1152/ajpendo.90997.2008. Epub 2009 Sep 1.
8
SIRT1 markedly extends replicative lifespan if the NAD+ salvage pathway is enhanced.如果NAD+补救途径得到增强,SIRT1可显著延长复制寿命。
FEBS Lett. 2009 Sep 17;583(18):3081-5. doi: 10.1016/j.febslet.2009.08.031. Epub 2009 Aug 29.
9
Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes.烟酰胺磷酸核糖基转移酶通过心肌细胞中的NAD⁺合成来调节细胞存活。
Circ Res. 2009 Aug 28;105(5):481-91. doi: 10.1161/CIRCRESAHA.109.203703. Epub 2009 Aug 6.
10
SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats.在糖尿病大鼠肝脏中敲低SirT1可降低基础肝糖生成并增强肝脏对胰岛素的反应性。
Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11288-93. doi: 10.1073/pnas.0812931106. Epub 2009 Jun 22.